22.4 %In the final study quarter, 22.4% of new clients at control facilities in Mombasa County, Kenya received HIV counseling.
KenyaVIH/sidapublished 2022Implementation science : ISeurope_pmcdocument of 6 observationsDOI 10.1186/s13012-022-01242-3
Gold tier: mechanically validated evidence, with its primary source.
2,235 evidence items · page 70 / 90
22.4 %In the final study quarter, 22.4% of new clients at control facilities in Mombasa County, Kenya received HIV counseling.
KenyaVIH/sidapublished 2022Implementation science : ISeurope_pmcdocument of 6 observationsDOI 10.1186/s13012-022-01242-3
12.1 %Among 470 pregnant women on antiretroviral treatment for at least 4 months, 57 (12.1%) had virologic non-suppression.
KenyaVIH/sidapublished 2021PloS onePubMeddocument of 6 observations
0.07 odds_ratioOdds of viral failure were 97% lower for those on third-line versus second-line regimens (OR = 0.07; 95% CI 0.02–0.20).
KenyaVIH/sidapublished 2025Journal of the International AIDS SocietyPubMeddocument of 15 observations
High levels of C-Reactive Protein (CRP) indicate enhanced inflammation processes associated with HIV infection.
KenyaVIH/sidapublished 2017Kenyatta University Institutional Repository (Kenyatta University)OpenAlexdocument of 7 observations
1.59 aRRThere was a higher rate of self-reported condomless sex at visits where women reported using modern contraceptives, but this difference was not statistically significant after adjustment for potential confounding factors (aRR 1.59, 95% CI 0.98–2.58).
KenyaVIH/sidaobserved October 2012 through September 2014published 2017PloS oneeurope_pmcdocument of 3 observations
7.3 %Among children in households with HIV-positive adults, the intervention led to a 7.3% increase in primary school completion after 3 years in intervention communities compared with control communities.
KenyaVIH/sidapublished 2022The Lancet. Global healthPubMeddocument of 6 observations
0.03 %Among 4451 women, 14 HIV retesting sessions had discrepant results, corresponding to a 95% confidence interval of 0.03% to 0.10%.
KenyaVIH/sidapublished 2021The Journal of infectious diseasesPubMeddocument of 3 observations
16.7 %Among 813 women enrolled in the Mobile WAChX trial in Kenya, the cumulative incidence of loss to follow-up was 16.7% by 6 months postpartum.
KenyaVIH/sidaobserved 6 months postpartumpublished 2023Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 6 observations
100 %Binding antibodies against Env were detected in up to 100% of recipients of DNA prime - rAd5 boost.
KenyaVIH/sidapublished 2010PloS oneeurope_pmcdocument of 4 observations
22 %Among 2250 pregnant women in Kenya, 22% did not know their partner's HIV status.
KenyaVIH/sidapublished 2025Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 8 observations
0 seroconversionsAmong 124 persons who sought PEP in a pilot study in five rural communities in Kenya and Uganda between December 2018 and May 2019, there were no HIV seroconversions.
Kenya · OugandaVIH/sidaobserved December 2018 to May 2019published 2021Journal of the International AIDS SocietyPubMeddocument of 11 observations
4.8 %Among Kenyan adolescents aged 15–19 years in Kisumu who engaged in transactional sex, 4.8% had used PrEP.
KenyaVIH/sidapublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 15 observations
31.1 %The proportion of vitamin D insufficiency was 31.1% among HAART-experienced participants.
KenyaVIH/sidapublished 2024BMC infectious diseasesPubMeddocument of 10 observations
55.7 odds_ratioAmino acid threonine at position 22 of V3 loop increased the odds of a strain being X4 by 55.7 times compared to alanine which occurred in CCR5-tropic strains.
KenyaVIH/sidapublished 2022MedicinePubMeddocument of 6 observations
3,519 individualsA total of 3,519 children aged 0–9 years living with HIV newly initiated antiretroviral therapy at 47 health facilities in central Kenya.
KenyaVIH/sidapublished 2022AIDS research and human retrovirusesPubMeddocument of 18 observations
97 %HIV self-testing completion was 97% among adolescents and young adults in an urban settlement in Kenya.
KenyaVIH/sidapublished 2022AIDS and behaviorPubMeddocument of 3 observations
120 infantsOf 626 enrolled infants, 120 (19.2%) received point-of-care HIV testing at 6 weeks only.
KenyaVIH/sidapublished 2020PloS onePubMeddocument of 13 observations
161 mother-infant pairsA total of 161 mother-infant pairs were included in the study, comprising 59 cases (HIV-positive mothers whose infants tested HIV-positive by DNA PCR) and 101 controls (HIV-positive mothers whose infants tested HIV-negative).
KenyaVIH/sidapublished 2026The Pan African medical journalPubMeddocument of 2 observations
1,100,000 inhabitants1.1 million Kenyans on antiretroviral therapy (ART) are HIV-seropositive.
KenyaVIH/sidapublished 2021MedicinePubMeddocument of 11 observations
115 copies_per_swabMost women with cervical HIV-1 RNA levels above the threshold for quantitation had low concentrations during cervical infections (median 115, range 100–820 copies per swab).
Kenyacervical infections · VIH/sidapublished 2010AIDS (London, England)europe_pmcdocument of 4 observationsDOI 10.1097/qad.0b013e32833f9f43
16.9 %HIV prevalence was 16.9% in Ndhiwa sub-county in 2018.
KenyaVIH/sidaobserved 2018published 2021Tropical medicine & international health : TM & IHPubMeddocument of 7 observations
42.5 USDThe average unit cost per male sex partner (MSP) tested was $42.50.
KenyaVIH/sidapublished 2022BMC health services researchPubMeddocument of 13 observations
25.5 %The prevalence of viral load non-suppression among treatment-experienced female sex workers in Kenya decreased from 25.5% in 2016 to 4.3% in 2021.
KenyaVIH/sidaobserved 2016published 2025AIDS (London, England)PubMeddocument of 5 observations
0.53 aHRNot being employed was negatively associated with poor outcomes (adjusted hazard ratio = 0.53, 95%CI 0.34–0.81).
KenyaVIH/sidapublished 2022PloS onePubMeddocument of 15 observations
34 %The proportion of adolescents and young people living with HIV on antiretroviral therapy whose viral load was resuppressed on repeat testing improved from 34% at baseline to 62% during the implementation period.
KenyaVIH/sidaobserved baselinepublished 2022BMJ open qualityPubMeddocument of 8 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.